VISION: An international, prospective, open-label, multicenter, randomized phase 3 study of (177)Lu-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Sartor, A. O.; Morris, M. J.; Krause, B. J. |
| Abstract Title: | VISION: An international, prospective, open-label, multicenter, randomized phase 3 study of (177)Lu-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 312s |
| Language: | English |
| ACCESSION: | WOS:000487345803378 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS5099 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS5099 -- Source: Wos |
